School of Medicine, European University Cyprus, Nicosia, Cyprus.
Front Immunol. 2023 Jan 9;13:1070367. doi: 10.3389/fimmu.2022.1070367. eCollection 2022.
Despite advancements in chemotherapy, the issue of resistance and non-responsiveness to many chemotherapeutic drugs that are currently in clinical use still remains. Recently, cancer immunotherapy has gathered attention as a novel treatment against select cancers. Immunomodulation is also emerging as an effective strategy to improve efficacy. Natural phytochemicals, with known anticancer properties, been reported to mediate their effects by modulating both traditional cancer pathways and immunity. The mechanism of phytochemical mediated-immunomodulatory activity may be attributed to the remodeling of the tumor immunosuppressive microenvironment and the sensitization of the immune system. This allows for improved recognition and targeting of cancer cells by the immune system and synergy with chemotherapeutics. In this review, we will discuss several well-known plant-derived biomolecules and examine their potential as immunomodulators, and therefore, as novel immunotherapies for cancer treatment.
尽管化疗技术不断进步,但目前临床应用的许多化疗药物仍然存在耐药性和无应答性的问题。最近,癌症免疫疗法作为一种针对特定癌症的新型治疗方法引起了人们的关注。免疫调节也作为一种提高疗效的有效策略而出现。具有已知抗癌特性的天然植物化学物质已被报道通过调节传统的癌症途径和免疫来发挥其作用。植物化学物质介导的免疫调节活性的机制可能归因于肿瘤免疫抑制微环境的重塑和免疫系统的致敏。这使得免疫系统能够更好地识别和靶向癌细胞,并与化疗药物产生协同作用。在这篇综述中,我们将讨论几种著名的植物来源的生物分子,并研究它们作为免疫调节剂的潜力,因此,作为癌症治疗的新型免疫疗法。
Front Immunol. 2022
Arch Pharm Res. 2021-11
Biomed Res Int. 2023
Semin Cancer Biol. 2021-2
Front Immunol. 2024
Int J Biol Macromol. 2024-10
Acc Chem Res. 2019-5-23
Drug Des Devel Ther. 2025-6-30
Biomolecules. 2024-10-2
Pharmaceuticals (Basel). 2024-1-18
Int J Mol Sci. 2023-3-9
Asian Pac J Cancer Prev. 2022-10-1
Cancers (Basel). 2022-9-19
J Pers Med. 2022-8-19
Int Immunopharmacol. 2022-9